Owlstone Medical presents data demonstrating progress in development of breath biopsy tests for liver cirrhosis and NASH

FHS
June 22, 2023
12:03 pm

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced new data on the development of novel tests for the detection of liver disease.

Curcumin boosts brain delivery of HIV drug, curbing inflammation and oxidative stress

Study shows curcumin enhances antiretroviral delivery and reduces inflammation and oxidative stress in HIV, offering potential improvements in treating HIV-associated neurocognitive disorders.

November 16, 2023

Sanofi pulls the plug on ADC after lung cancer PhIII disappoints

The only clinical-stage antibody-drug conjugate in Sanofi’s pipeline has flunked a Phase III study, pushing the French drugmaker to wind down the entire development program.

December 22, 2023

SK bioscience and Sanofi expand agreement for PCVs

SK bioscience retains exclusive rights in Korea, with Sanofi handling other markets and paying royalties on international sales. Credit: SK bioscience. SK bioscience and Sanofi

December 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.